Oxymetazoline Hydrochloride; Tetracaine Hydrochloride Patent Expiration
Oxymetazoline Hydrochloride; Tetracaine Hydrochloride is Used for local anesthesia in the maxillary dental arch. It was first introduced by St Renatus Llc
Oxymetazoline Hydrochloride; Tetracaine Hydrochloride Patents
Given below is the list of patents protecting Oxymetazoline Hydrochloride; Tetracaine Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Kovanaze | US8580282 | Dental anesthetic comprising tetracaine and a vasoconstrictor for intranasal administration | Apr 02, 2030 | St Renatus |
| Kovanaze | US9308191 | Dental anesthetic comprising tetracaine and a vasoconstrictor for intranasal administration | Apr 02, 2030 | St Renatus |
| Kovanaze | US6413499 | Methods and kits for maxillary dental anesthesia by means of a nasal deliverable anesthetic |
Mar 20, 2020
(Expired) | St Renatus |
Oxymetazoline Hydrochloride; Tetracaine Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List